EverQuote (EVER)
(Delayed Data from NSDQ)
$18.12 USD
-0.68 (-3.62%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $18.13 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.12 USD
-0.68 (-3.62%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $18.13 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Zacks News
EverQuote (EVER) Rallies 137.7% in a Year: More Room to Run?
by Zacks Equity Research
EverQuote (EVER) gains from reduced operating expenses, the enhancement of its platform via machine learning and artificial intelligence, and expected recovery in the auto insurance business.
Are You Looking for a Top Momentum Pick? Why EverQuote (EVER) is a Great Choice
by Zacks Equity Research
Does EverQuote (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why Investors Should Hold Everest Group (EG) Stock
by Zacks Equity Research
Everest Group (EG) stands to gain from an improved interest rate environment, strong renewal retention, continued favorable rate increases and a solid capital position.
Hartford Financial (HIG), Active Minds Join to Enhance Offerings
by Zacks Equity Research
Hartford Financial (HIG) collaborates with Active Minds to provide a mental health guide to employees.
EverQuote (EVER) Up 3.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Does EverQuote (EVER) Have the Potential to Rally 29.3% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for EverQuote (EVER) points to a 29.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Should You Hold EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) stands to gain from reduced operating expenses, revenue growth within the health direct-to-consumer agency and a robust capital position.
EverQuote (EVER) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does EverQuote (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Hartford Financial (HIG) & Origin Partner to Enhance Offerings
by Zacks Equity Research
Hartford Financial (HIG) collaborates with Origin to provide financial education tools to U.S. employees.
Wall Street Analysts Predict a 41.51% Upside in EverQuote (EVER): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 41.5% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
EverQuote (EVER) Q4 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
EverQuote (EVER) fourth-quarter results reflect the weak performance of both Automotive and Other insurance verticals. However, lower expenses limit the downside.
EverQuote (EVER) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for EverQuote (EVER) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
EverQuote (EVER) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 38.71% and 11.66%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Surges 8.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
EverQuote (EVER) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Horace Mann (HMN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of 29.23% and 2.16%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
EverQuote (EVER) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
Here's Why EverQuote (EVER) Shares Are Attracting Investors Now
by Zacks Equity Research
EverQuote (EVER) stands to gain from the solid performances of home and renters' insurance, and enhanced capital efficiencies.
Should You Buy EverQuote (EVER) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
How Much Upside is Left in EverQuote (EVER)? Wall Street Analysts Think 26.23%
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
EverQuote (EVER) Up 17% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain EverQuote (EVER) in Your Portfolio
by Zacks Equity Research
EverQuote (EVER) stands to gain from the solid performance of home and renters' insurance and enhanced capital efficiencies.
EverQuote (EVER) Q3 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
EverQuote (EVER) third-quarter results reflect the weak performance of both Automotive and Other insurance verticals. However, lower expenses limit the downside.
EverQuote (EVER) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 44.44% and 5.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: EverQuote (EVER) Q3 Earnings Expected to Decline
by Zacks Equity Research
EverQuote (EVER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold EverQuote (EVER) in Your Portfolio
by Zacks Equity Research
EverQuote (EVER) stands to gain from innovating advertiser products and services, increasing traffic volumes and a robust capital position.